Try
Repligen Corporation Common Stock
RGENUnited States
109 filed reports · 661 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
109 reports · Mar 2010 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 502 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 46 | 6,438 | Jun 2011 to Jun 2026 |
| Current · 8-KSEC EDGAR | 42 | 506 | Mar 2010 to Mar 2021 |
| Annual · 10-KSEC EDGAR | 15 | 6,861 | Dec 2011 to Dec 2025 |
| Quarterly · 10-Q/ASEC EDGAR | 5 | 945 | Mar 2023 to Jun 2024 |
| Annual · 10-K/ASEC EDGAR | 1 | 529 | Dec 2023 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 29, 2026 | 374 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 245 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 954 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 4, 2025 | 225 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 195 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | Apr 29, 2025 | 192 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 14, 2025 | 602 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 18, 2024 | 110 | Open |
| FY2024 Q2 | 10-Q/A | Jun 30, 2024 | Nov 18, 2024 | 104 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Jul 30, 2024 | 2 | Open |
| FY2024 Q1 | 10-Q/A | Mar 31, 2024 | Nov 18, 2024 | 174 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 1, 2024 | 2 | Open |
Financial data
661 concepts · 15,279 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial636 concepts · 14,525 facts · Mar 2001 to Jul 2026
- Cash and cash equivalents at carrying value84 · Mar 2010 to Jun 2026
- Common stock shares issued83 · Mar 2011 to Jun 2026
- Net income loss83 · Mar 2010 to Jun 2026
- Costs and expenses82 · Mar 2010 to Jun 2026
- Investment income net82 · Mar 2010 to Jun 2026
- Operating income loss82 · Mar 2010 to Jun 2026
- Research and development expense82 · Mar 2010 to Jun 2026
- Revenue82 · Mar 2010 to Jun 2026
- Selling general and administrative expense82 · Mar 2010 to Jun 2026
- Share based compensation82 · Mar 2010 to Jun 2026
- Stockholders equity (US GAAP)82 · Mar 2010 to Jun 2026
- Depreciation and amortization81 · Mar 2010 to Jun 2026
- Increase decrease in accounts payable81 · Mar 2010 to Jun 2026
- Increase decrease in accounts receivable81 · Mar 2010 to Jun 2026
- Increase decrease in accrued liabilities81 · Mar 2010 to Jun 2026
- Increase decrease in inventories81 · Mar 2010 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets81 · Mar 2010 to Jun 2026
- Payments to acquire property plant and equipment81 · Mar 2010 to Jun 2026
- Goodwill (US GAAP)80 · Mar 2011 to Jun 2026
- Accounts payable current79 · Mar 2011 to Jun 2026
- Accounts receivable net current79 · Mar 2011 to Jun 2026
- Accrued liabilities current79 · Mar 2011 to Jun 2026
- Allowance for doubtful accounts receivable current79 · Mar 2011 to Jun 2026
- Assets79 · Mar 2011 to Jun 2026
Guidance16 concepts · 506 facts · Apr 2010 to May 2021
- Revenue Guidance84 · Apr 2010 to May 2021
- Net Income Guidance78 · Apr 2010 to May 2021
- Operating Income Guidance60 · Aug 2013 to May 2021
- Gross Margin Guidance46 · Nov 2014 to May 2021
- EPS (Diluted) Guidance44 · May 2016 to May 2021
- Revenue Growth Guidance40 · Nov 2014 to May 2021
- EPS (Diluted) Guidance (Adjusted (non-GAAP))26 · May 2016 to Feb 2021
- Net Income Guidance (Adjusted (non-GAAP))26 · May 2016 to Feb 2021
- Operating Income Guidance (Adjusted (non-GAAP))24 · May 2016 to Feb 2021
- Gross Margin Guidance (Adjusted (non-GAAP))18 · Aug 2017 to Feb 2021
- Effective Tax Rate Guidance16 · Mar 2014 to May 2021
- Revenue Growth Guidance (Organic)14 · Nov 2018 to Feb 2021
- Revenue Growth Guidance (Constant currency)12 · Aug 2017 to Feb 2021
- Effective Tax Rate Guidance (Adjusted (non-GAAP))10 · Aug 2019 to Feb 2021
- Gross Margin Guidance (product)6 · May 2016 to Nov 2016
- Revenue Growth Guidance (Organic, constant currency)2 · May 2018
Product5 concepts · 179 facts · Dec 2014 to Jun 2026
- Revenue167 · Dec 2014 to Jun 2026
- Chromatography products8 · Mar 2019
- Revenue from related parties2 · Dec 2019 to Dec 2020
- Payment as component for product revenue1 · Mar 2023
- Revenue from contract with customer including assessed tax1 · Mar 2023
Geography4 concepts · 69 facts · Dec 2011 to Dec 2025
- Total Assets46 · Dec 2011 to Dec 2025
- Revenue20 · Jun 2017 to Sep 2018
- Effective income tax rate reconciliation at federal statutory income tax rate2 · Dec 2012 to Mar 2013
- Open tax year1 · Mar 2018
Segments
248 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis8 members · 163 facts
- Product49 · Dec 2016 to Jun 2026
- Royalty47 · Dec 2016 to Jun 2026
- Chromatography Products15 · Dec 2016 to Dec 2025
- Filtration Products14 · Dec 2016 to Dec 2025
- Other Products14 · Dec 2016 to Dec 2025
- Proteins Products10 · Dec 2017 to Dec 2025
- Process Analytics Products7 · Dec 2019 to Dec 2025
- Protein Products7 · Dec 2016 to Mar 2019
Statement geographicalus-gaap:StatementGeographicalAxis12 members · 35 facts
- Europe10 · Dec 2016 to Dec 2025
- Us7 · Dec 2011 to Dec 2017
- Se6 · Dec 2011 to Dec 2016
- Sg2 · Dec 2015 to Dec 2016
- SE2 · Dec 2012 to Mar 2013
- Asia2 · Dec 2016 to Dec 2017
- All Other1 · Mar 2018
- Asia Pacific1 · Mar 2018
- De1 · Dec 2016
- DE1 · Mar 2018
- Europe1 · Mar 2018
- North America1 · Mar 2018
Statement geographicalsrt:StatementGeographicalAxis6 members · 34 facts
- Apac9 · Dec 2017 to Dec 2025
- North america9 · Dec 2017 to Dec 2025
- All Other4 · Jun 2017 to Sep 2018
- Asia And Australia4 · Jun 2017 to Sep 2018
- Europe4 · Jun 2017 to Sep 2018
- North America4 · Jun 2017 to Sep 2018
Product or serviceus-gaap:ProductOrServiceAxis4 members · 16 facts
- Chromatography Products4 · Dec 2014 to Dec 2017
- Filtration Products4 · Dec 2014 to Dec 2017
- Other Products4 · Dec 2014 to Dec 2017
- Protein Products4 · Dec 2014 to Dec 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary103 claims from 10 reports · Jun 2024 to Jun 2026
- Management discussion (MD&A) commentary265 claims from 14 reports · Mar 2023 to Jun 2026
- Risk-factor changes31 claims from 2 reports · Dec 2024 to Dec 2025
- Risk factors131 risks from 3 annual reports · 2023 to 2025
Earnings calls
1 calls · Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 28, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.